April 25, 2025
| Today’s news and insights for medtech leaders
Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by Abbott.
|
Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June 30.
|
Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board members think the agency should keep its leading role.
|
Tell your brand’s story. Secure prime ad placements. Generate qualified leads. Reach your marketing goals with MedTech Dive’s audience of over 206,500 decision makers.
|
Avanos did not offer Greiner a position comparable to the one he held before becoming interim CEO last year.
|
The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity constraints that have dogged its core business.
|
The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the impact of the tariffs.
|
Commercial + Medical to Drive Speed & Patient Outcomes
|
|
From Our Library
Custom content for Salesforce
|
Playbook
Custom content for Hy-Tek Intralogistics
|
Playbook
Custom content for Salesforce & Cognizant
|
| 
